Dec 19 (Reuters) - BioMarin Pharmaceutical (BMRN) said on Friday it would acquire Amicus Therapeutics (FOLD) for about $4.8 billion, expanding its presence in rare metabolic diseases.
The drugmaker will pay $14.50 per share for Amicus, a premium of 33.1% to the stock's last close. Shares of Amicus surged 30%, while BioMarin rose nearly 5% in premarket trading.
The deal strengthens BioMarin's portfolio with Amicus' approved genetic disorder treatments including Galafold, an oral drug for Fabry disease, which is caused by a faulty gene that leads to a buildup of fatty substances in cells.
Amicus also markets a combination therapy Pombiliti and Opfolda for Pompe disease, a genetic condition in which a complex sugar called glycogen builds up in the body's cells.
Amicus also has U.S. rights to DMX-200, a potential treatment of a type of kidney disease known as focal segmental glomerulosclerosis.
BioMarin intends to finance the deal through a combination of cash on hand and about $3.7 billion of non-convertible debt financing.
The company's total cash and investments at the end of September 30 were about $2 billion.
The acquisition, which is expected to close in the second quarter of 2026, will add revenue immediately after the transaction closes, BioMarin said.
The deal is also expected to add to adjusted profit in the first 12 months after close and be substantially accretive beginning in 2027, the company said.
(Reporting by Christy Santhosh and Sriparna Roy in Bengaluru; Editing by Leroy Leo and Maju Samuel)
latest_posts
- 1
Reports: Germany plans expansion of foreign intelligence powers - 2The Effect of Online Organizations on Society: Beating the Difficulties
- 3Which Film Has the Incomparable Melodic Score?
- 4Comet MAPS faces a make-or-break moment as it dives toward the sun on April 4 — could it shine in the daytime sky?
- 5Unfathomable and Entertaining Legal disputes That Surprise everyone
- Novo and Lilly cut prices of weight-loss drugs in China
- BHP liable for 2015 Brazil mine disaster: UK court
- In Antarctica, photos show a remote area teeming with life amid growing risks from climate change
- These HGTV stars made a pledge to keep their kids off smartphones. Here's how it's going.
- Instructions to Pick the Right Toothpaste for Your Dental Requirements
- The next frontier in space is closer than you think – welcome to the world of very low Earth orbit satellites
- The most effective method to Promoter for Cellular breakdown in the lungs Mindfulness in Your People group
- A definitive Bike Standoff: Decision in favor of Your Number one Ride
- NASA Artemis 2 astronauts to make historic moon flyby today. Here's what to expect hour by hour (timeline)
